Sonic Healthcare Ltd

SHL: XASX (AUS)
View Stock Summary
Morningstar Rating for StocksFair ValueEconomic MoatCapital Allocation
C&!LOCK|$PjqLOCK|fBBzHY&

Sonic Healthcare: Strong Start to the Year; Shares Undervalued

Sonic Healthcare reaffirmed fiscal 2026 EBITDA guidance of 8% growth at the midpoint in constant currency terms, with solid organic sales growth of 5% year to date. Management also guides to modestly lower fiscal 2026 depreciation and interest expense. Shares reacted positively, up 6%.

Sponsor Center